XML 134 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Option Plans and 401(k) Plan (Tables)
12 Months Ended
Mar. 31, 2013
Text Block [Abstract]  
Share-based compensation expense
    Fiscal Years Ended March 31,  
    2013     2012  
Research and development expense:            
related to stock option grants   $ 242,300     $ 477,400  
related to warrant grants to officers and directors     267,500       -  
      509,800       477,400  
General and administrative expense:                
related to stock option grants     196,600       1,113,900  
related to warrant grants to officers and directors     534,900       -  
      731,500       1,113,900  
Total share-based compensation expense   $ 1,241,300     $ 1,591,300  
Black-Scholes option valuation model assumptions for share-based compensation expense
    Fiscal Years Ended March 31,  
    2013     2012  
             
Exercise price   $0.51 and $0.75     $ 1.75 to $2.99  
Market price on date of grant   $0.51 and $0.71     $ 1.75 to $2.99  
Risk-free interest rate   0.895% to 1.74%     1.19% to 3.39%  
Expected term (years)   6.25 to 10.0     6.25 to 10.0  
Volatility   82.9% to 85.4%     78.9% to 91.3%  
Expected dividend yield     0%       0%  
                 
Fair value per share at grant date   $ 0.36 to $0.59     $ 1.08 to $2.48  
Summary of stock option plan activity
    Fiscal Years Ended March 31,  
    2013     2012  
          Weighted           Weighted  
          Average           Average  
    Number of     Exercise     Number of     Exercise  
    Shares     Price     Shares     Price  
 Options outstanding at beginning of period     4,805,771     $ 1.53       3,949,153     $ 1.42  
 Options granted     1,075,550     $ 0.72       1,020,000     $ 1.88  
 Options exercised     -     $ -       (113,979 )   $ 0.88  
 Options cancelled     (870,550 )   $ 1.72       -     $ -  
 Options forfeited     (29,167 )   $ 1.75       (30,000 )   $ 1.75  
 Options expired     (69,000 )   $ 1.34       (19,403 )   $ 0.80  
                                 
 Options outstanding at end of period     4,912,604     $ 1.32       4,805,771     $ 1.53  
 Options exercisable at end of period     4,227,436     $ 1.35       3,740,135     $ 1.45  
 Weighted average grant-date fair value of                                
options granted during the period           $ 0.52             $ 1.36  
Stock options outstanding and exercisable under Company's option plan
      Options Outstanding     Options Exercisable  
            Weighted                    
            Average     Weighted           Weighted  
            Remaining     Average           Average  
Exercise     Number     Years until     Exercise     Number     Exercise  
Price     Outstanding     Expiration     Price     Exercisable     Price  
$ 0.51 - $0.72       267,540       7.05     $ 0.60       112,540     $ 0.72  
$ 0.75       920,550       9.58     $ 0.75       670,494     $ 0.75  
$ 0.80 - $1.13       455,776       3.83     $ 1.00       455,776     $ 1.00  
$ 1.50       2,413,250       6.68     $ 1.50       2,413,250     $ 1.50  
$ 1.65 - $1.925       695,833       5.99     $ 1.76       415,721     $ 1.74  
$ 2.10 - $2.99       159,655       5.08     $ 2.16       159,655     $ 2.16  
                                             
          4,912,604       6.83     $ 1.32       4,227,436     $ 1.35